Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Quetiapine Fumarate I.P. 50mg Tablet
Therapeutic Category
Antipsychotic, Neurology, Sedative or Antianxiety
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹89/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Qtpair 50 Tablet contains Quetiapine Fumarate, a second-generation antipsychotic, used for treating schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. Quetiapine works by affecting the balance of neurotransmitters in the brain, specifically serotonin and dopamine, thereby improving mood, reducing anxiety, and preventing psychotic episodes.
This medication is available in 50mg dosage, suitable for patients requiring a moderate dose of Quetiapine. It may also be prescribed to control symptoms of mania in bipolar disorder or to prevent mood swings associated with it. Additionally, it has demonstrated efficacy in treating major depressive disorder as part of combination therapy when other treatments do not provide sufficient relief.
Common side effects include drowsiness, dizziness, dry mouth, weight gain, and increased cholesterol. Rare side effects may include movement disorders, low blood pressure, and elevated blood sugar.
Treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder.
Consult your doctor before stopping or adjusting the dosage, particularly for those with pre-existing heart conditions or the elderly.
Store in a cool, dry place away from heat and moisture. Keep out of reach of children.
Composition : Amisulpride (50mg) Tablet
Composition : Sertraline 25mg Tablet
Composition : Amisulpride 100mg Tablet
Composition : Amisulpride 200mg Tablet
Composition : Sertraline 100mg Tablet
Composition : Quetiapine Fumarate I.P. 25mg Tablet
Composition : Quetiapine Fumarate I.P. 100mg Tablet
Composition : Paroxetine I.P. 12.5mg Prolonged Release Tablets
Composition : Paroxetine I.P. 25mg Prolonged Release Tablets
Composition : Pregabalin (75mg) + Nortriptyline (10mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Quetiapine Tablets (50 mg) have strong demand in the psychiatry and CNS segment, making them a key mid-dose product for pharma distributors, wholesalers, and franchise partners. It is widely used in the management of schizophrenia, bipolar disorder, and mood disorders, ensuring consistent long-term prescription-based demand.
Medical distributors and agencies benefit from the high and stable demand for psychiatric maintenance therapy. Commonly used as a mid-dose option in schizophrenia and bipolar disorder treatment Also used in adjunct therapy for depression and mood stabilization Sometimes prescribed for sleep and behavioral disturbances under medical supervision Widely prescribed by psychiatrists and neurophysicians Strong demand due to chronic nature of psychiatric disorders Ensures regular monthly prescription cycles and long-term usage This makes it a steady and high-retention CNS product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Quetiapine Fumarate 50 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent psychiatric prescription flow, strong demand in long-term mental health treatment, repeat monthly sales, and stable growth in the CNS segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete CNS product portfolio access to build a strong presence in the psychiatry and neurocare market.